Navigation Links
Blood vessel mapping reveals 4 new 'ZIP codes'
Date:10/24/2011

se (fat) tissue vasculature. In earlier research, targeting of prohibitin with an apoptotic agent caused dramatic weight loss in obese rodents. The lab is applying to the Food and Drug Administration (FDA) to conduct a clinical trial for a new drug that will test this principle for weight loss in humans.

Moving the impact forward

This project establishes that large-scale study of the human vasculature can uncover many unidentified or unique molecular networks that can contribute to the treatment of many diseases.

"This endeavor and the applications of our findings are exciting," Arap said. "There are going to be many more receptors and many levels of diversity. We've just scratched the surface."

Translational applications, such as first-in-man clinical trials, have started within MD Anderson. The FDA has granted a safe-to-proceed status for the first vascular-targeted Investigational New Drug (IND). Three other drugs are in pre-IND stage, and several others are in pre-clinical laboratory phase.

"I believe these strategies to identify therapeutic targets on the vasculature are truly innovative both from a scientific and clinical perspective," said David Cheresh, Ph.D., associate director for Translational Research at the University of California, San Diego Cancer Center and noted authority on angiogenesis and cancer metastasis. "Identifying such targets will ultimately pave the way for the next generation of smart/targeted cancer therapies."

MD Anderson and some of its researchers, including Arap and Pasqualini, have equity positions in drug-development companies Alvos Therapeutics and Ablaris Therapeutics, which are subjected to certain restrictions under institutional policy. MD Anderson manages and monitors the terms of these arrangements in accordance with its conflict-of-interest policy.


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. E-counselling shows dramatic results in lowering blood pressure
2. Blood-pressure-lowering drug after stroke aids recovery, study finds
3. Inflammatory Bowel Disease Tied to Higher Risk of Post-Op Blood Clots
4. Hypertension, Not Blood Pressure Drugs, Linked to Birth Defects
5. New U of M start-up may save lives of victims of massive blood loss and trauma
6. Blood Type May Affect Survival After Heart Bypass
7. Stem cells from cord blood could help repair damaged heart muscle
8. Study Suggests Origins of Pregnancy-Linked High Blood Pressure
9. Experts find continuous glucose monitoring beneficial in maintaining target blood glucose levels
10. Restless legs syndrome may raise high blood pressure risk in middle-aged women
11. Restless Legs Syndrome May Boost Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015 The Radiology Business ... members with applied business information and intelligence, is proud ... weekly email newsletter for its more than 2,000 members. ... care legislative news sources in that it is exclusively ... business of radiology. The newsletter is produced in cooperation ...
(Date:4/27/2015)... April 27, 2015 Cambia Health ... has joined its team as Operating Partner within ... focused on investing in and building companies that change ... his new role, Albert will be responsible for accelerating ... so that it is both economically sustainable and person-focused, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Health conscious ... have a first-of-its-kind bakery right on their doorstep, which ... for those on restrictive and low-carbohydrate diets. ... grain, and starch free, and will use only natural ... May 1, 2015, strives to provide specialty food that ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 ... 21, 2015 in the U.S. District Court, Northern ... lawsuits ( http://www.testosteronelawsuithub.com/ ) have been consolidated ... to court documents, matters addressed included the intention ... of claims involving their products on preemption grounds, ...
(Date:4/26/2015)... With the FCPX LUT B&W pack from Pixel ... quickly and easily add desaturated color grades to footage. A ... for modifying an image. The LUT changes every pixel's color ... comes with 60 black and white CUBE LUT files. , ... white films. With the FCPX LUT B&W Loader from ...
Breaking Medicine News(10 mins):Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2Health News:Cambia Welcomes Ben Albert as Operating Partner 2Health News:Cambia Welcomes Ben Albert as Operating Partner 3Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2
... Security Risks in Exotic Locales , ... Baltimore, MD ... in a down economy should prepare for unexpected medical and security ... vacation. Old and new destinations offering steep discounts may carry risks ...
... kick the habitOLYMPIA, Wash., March 31 A new federal ... cost of a pack of cigarettes by 62 cents. Public ... to quit smoking. The Department of Health,s toll-free Tobacco Quit ... expected loss in sales as more people quit smoking, several ...
... Conference , April 4 - 8 in ChicagoCHICAGO, March 31 ... leading Workforce Management consulting firm, has ... practice dedicated to the Workforce Management (WFM) needs of the ... HIMSS09 , the Healthcare Information and Management ...
... WASHINGTON, March 31 The following is being issued ... 1, at 12:00 noon, D.C. area Pro-life leaders and ... change in HHS regs regarding conscience for health care ... abortion or chemical birth control.A local physician will be ...
... COMPLAINT & ATTORNEY INTERVIEWS AVAILABLE -SEATTLE, March 31 ... tracheal tube clogged with mucous causing oxygen loss and ... Aldercrest Health & Rehabilitation Center in Edmonds, Wash., has ... States-based subsidiaries of Canadian Extendicare REIT. Norene McPherson,s 49-year-old ...
... testimony today before the U.S. Senate Committee on Agriculture, ... revise school food nutrition standards so that more nutritious ... federal nutrition standards for foods sold outside of the ... updated since the late 1970s. , ...
Cached Medicine News:Health News:Don't Sacrifice Your Well-being in a Discount Destination 2Health News:Don't Sacrifice Your Well-being in a Discount Destination 3Health News:Federal Tobacco Tax Increase a Good Reason to Quit Smoking 2Health News:Axsium Group Launches Workforce Management Practice for Healthcare Industry 2Health News:Axsium Group Launches Workforce Management Practice for Healthcare Industry 3Health News:Elder Abuse Complaint Filed Against Extendicare 2Health News:Elder Abuse Complaint Filed Against Extendicare 3Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 2Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 3
(Date:4/27/2015)... , April 27, 2015 BRH ... filing of a Pre-Marketing Notification Application (510k) with the ... Wound Management System. BRH Medical expects feedback from the ... US market with BRH-A2 following FDA pre-market clearance. Additional ... Motti Oderberg , CEO for BRH Medical, commented, ...
(Date:4/27/2015)... BANGALORE, India , April 27, 2015 ... Granted a Process Patent by the State Intellectual Property Office ... Cell Drug Based on Pooling Technology  - A ... Limb Ischemia (CLI)    - About 20% of ... the Prevalence in Women is Substantially Higher Than in Men. ...
(Date:4/26/2015)... 26, 2015  Ikonopedia announced today that its ... have been selected for use by BelleBridge, which ... and diagnostic examinations. Ikonopedia will showcase its suite ... Breast Imaging,s SBI/ACR Breast Imaging Symposium in ... (SBI Booth #216). BelleBridge is an ...
Breaking Medicine Technology:BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 3Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 4
... Corporation (NYSE: SGP ) today reported that interim ... (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent ... virus (HCV) genotype 1. In the lead-in arms ... lead-in of PEGINTRON(R) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) ...
... Sciences, Inc. (Nasdaq: CALP ), a leading provider of ... from the United States Food and Drug Administration (FDA) on ... screening and characterization assays for biological drugs. , "We were ... platform to a large group of reviewers. We believe the ...
Cached Medicine Technology:Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 2Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 3Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 4Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 5Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 6Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 7Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 8Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration 2
Small, compact and versatile, the CLK-4 light source is compatible with all Olympus fiberscopes and is ideal for the vast majority of routine fiber-endoscopic procedures, especially in the out-patien...
The pediatric blanket provides full coverage for pediatric patient care. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also red...
The under-patient design of the pediatric full access blanket warms even the tiniest patients while allowing full access for surgeons and staff....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers. Polyethylene cover....
Medicine Products: